| LaZure Technologies, LLC Patent applications |
| Patent application number | Title | Published |
|---|
| 20110060393 | SYSTEM AND METHOD FOR ENERGY DELIVERY TO A TISSUE USING AN ELECTRODE ARRAY - Devices, systems, and related methods for electric fields delivery for preferential destruction of cancerous cells and tissue ablation. | 03-10-2011 |
| 20110015630 | DEVICE AND METHOD FOR DESTRUCTION OF CANCER CELLS - The present invention provides devices and systems, as well as methods, of electric field delivery and non-thermal or selective ablation of target tissue regions, including selective ablation of cancerous cells and solid tumors. A method of the present invention includes delivering an electric field to a tissue, including positioning an electrode within a target tissue region comprising cancerous cells, and applying an alternating electrical current to the target tissue so as to non-thermally ablate cancerous cells of the target tissue region around the electrodes. | 01-20-2011 |
| 20100100093 | SYSTEM AND METHOD FOR CONTROLLED TISSUE HEATING FOR DESTRUCTION OF CANCEROUS CELLS - Methods and systems for delivering electrical energy for controlled heating or hyperthermia to a target tissue of a patient for destruction of cancerous cells or tissue. | 04-22-2010 |
| 20090076502 | Prostate cancer ablation - Methods and systems for delivering electrical energy and controlled, mild hyperthermia to a prostate tissue of a patient for destruction of cancerous and/or hyperplastic tissue. A method includes positioning a plurality of electrodes in a target tissue region comprising the prostate tissue, and establishing an alternating electrical current flow through a volume of the prostate tissue to induce mild heating and destruction of cancerous cells in the volume. | 03-19-2009 |
| 20090076500 | MULTI-TINE PROBE AND TREATMENT BY ACTIVATION OF OPPOSING TINES - The present invention provides devices and systems, as well as methods, of electric field delivery and non-thermal or mild hyperthermia, and preferential or selective ablation of cancerous cells of target tissue regions. A method can include, for example, advancing a probe comprising a plurality of electrodes to a target tissue region comprising cancerous cells, and deploying the plurality of electrodes from a distal portion of a probe, and applying an alternating current so as to provide one or more electric fields extending through the volume and selectively or preferentially destroy cancerous cells within the volume. | 03-19-2009 |
| 20090076499 | MULTI-LAYER ELECTRODE ABLATION PROBE AND RELATED METHODS - Electric field delivery and ablation of target tissue regions, including cancerous cells and solid tumors. Methods and systems include delivering an electric field to a target tissue, and may include positioning a first electrode or plurality to at least partially define a first treatment volume in the target tissue; positioning a second electrode or plurality to at least partially define a second treatment volume, the first volume is disposed in the second volume; and establishing a first current flow extending through the first volume and a second current flow extending through the second volume. | 03-19-2009 |
| 20090076496 | PROSTATE CANCER ABLATION - Methods and systems for delivering electrical energy and controlled, mild hyperthermia to a prostate tissue of a patient for destruction of cancerous and/or hyperplastic tissue. A method includes positioning a plurality of electrodes in a target tissue region comprising the prostate tissue, and establishing an alternating electrical current flow through a volume of the prostate tissue to induce mild heating and destruction of cancerous cells in the volume. | 03-19-2009 |
| 20090076494 | Transurethral systems and methods for ablation treatment of prostate tissue - Transurethral systems and methods for delivering electrical energy and controlled, mild heating to a prostate tissue of a patient for destruction of cancerous and/or hyperplastic tissue. A method includes positioning an elongate urethral probe having an expandable member with electrode elements at a target location in the patient's urethra, and inflating or expanding at the target location. Secondary electrodes are positioned within or adjacent to the prostate tissue and spaced from the electrode elements of the expandable member, and an alternating electrical current flow is established between the electrode elements of the expandable member and the one or more secondary electrodes. Current delivery can be selected so as to destroy or ablate cancerous cells of the prostate tissue. | 03-19-2009 |
